SC relief to GSK, junks plea claiming deficiency of service by Pharma company on account of alleged vaccine side effects
The apex court said that non-mentioning of myositis as an adverse reaction in the literature accompanying the injection or on the vial, did not amount to "deficiency of service" on the part of the pharma company.
Advertisement
New Delhi: The Supreme Court has dismissed a plea by a man against an order of the National Consumer Disputes Redressal Commission (NCDRC) which held that he has miserably failed to establish deficiency in service on the part of GlaxoSmithKline Pharmaceuticals Ltd in relation to the administration of a hepatitis vaccine.
According to the case, the man in order to achieve immunity against contracting Hepatitis B approached his family physician to administer the repeat dose of the vaccine Engerix-B, along with his family members.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.